Mark Lankisch und Wilfried Dinh - Info zur Person

(1 - 6 von 8

)

Insulin resistance and glycemic abnormalities are associated with...

cardiab.biomedcentral.com

Wilfried Dinh†Email author,; Mark Lankisch,; Werner Nickl†,; Daniel Scheyer,; Thomas Scheffold,; Frank Kramer,; Thomas Krahn,; Rolf M Klein, ...

OPUS 4 | Growth-differentiation factor-15: A novel biomarker in...

opus.bibliothek.uni-augsburg.de

Growth-differentiation factor-15: A novel biomarker in patients with diastolic dysfunction? Wilfried Dinh, Reiner Füth, Mark Lankisch, Georg Hess, Dietmar ...

Limiting esophageal temperature in radiofrequency ablation of left...

bmccardiovascdisord.biomedcentral.com

... Osman Tutdibi,; Karsten Pomsel,; Wilfried Dinh,; Reiner Füth,; Mark Lankisch,; Thomas Glosemeyer-Allhoff,; Jan Janssen and; Micheal Müller.

Limiting esophageal temperature in radiofrequency ablation of left ...core.ac.uk › MUCC (Crossref)

core.ac.uk

By Armin Sause, Osman Tutdibi, Karsten Pomsel, Wilfried Dinh, Reiner Füth, Mark Lankisch, Thomas Glosemeyer-Allhoff, Jan Janssen and Micheal Müller.

Insulin resistance and glycemic abnormalities are associated with...

cyberleninka.org

Wilfried Dinh ,, ', Mark Lankisch ,, Werner Nickl ', Daniel Scheyer , Thomas Scheffold ,, Frank Kramer, Rolf M Klein6, Michael Coll Barroso3, Reiner Füth1,2.